BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
HOPE
Hope Bancorp, Inc.
HOPE has a slight edge over BAC overall, supported by stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HOPE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HOPE's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOPE.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HOPE in the historical PE scenario, which offers more potential upside but is not a forecast.
HOPE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.2x | $7.46 | -43% |
| Fair | 10x | $10.89 | -17% |
| Forward | 11x | $13.06 | — |
| Current | 13x | $13.06 | — |
| Expensive | 16x | $16.93 | +30% |
Historical ranges are pointers, not guarantees.
HOPE's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over HOPE on the outlook, with more favorable profitability expectations.
HOPE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for HOPE, but weaker profitability. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over HOPE on earnings, with more consistent year-over-year improvement.
HOPE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.18 | +14% |
| Q3 2026 | $1.04 | +167% |
| Q2 2026 | $1.00 | +186% |
| Q1 2026 | $0.52 | -33% |
| Q4 2025 | $0.46 | -44% |
| Q3 2025 | $0.39 | -54% |
| Q2 2025 | $0.35 | -61% |
| Q1 2025 | $0.78 | -22% |
| Q4 2024 | $0.82 | -27% |
HOPE's earnings per share have fallen from their peak: $1.04 over the past year, against $1.81 in early 2022. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over HOPE on profitability, with a higher operating margin.
HOPE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $157.5M | +11% |
| Q2 2026 | $147.8M | +56% |
| Q1 2026 | $141M | +21% |
| Q4 2025 | $145.8M | +24% |
| Q3 2025 | $142M | +22% |
| Q2 2025 | $94.6M | -19% |
| Q1 2025 | $116.5M | -5.5% |
| Q4 2024 | $118M | -13% |
HOPE's revenue has grown year over year for five quarters in a row: $157M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +3.6 points |
| Q2 2026 | 29% | +60 points |
| Q1 2026 | 27% | +3 points |
| Q4 2025 | 27% | +1.1 points |
| Q3 2025 | 26% | -1.8 points |
| Q2 2025 | -32% | -61 points |
| Q1 2025 | 24% | -5.2 points |
| Q4 2024 | 26% | +0.9 points |
HOPE's operating margin was 29% last quarter, up 3.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HOPE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $146.1M | +210% |
| Q2 2026 | $56M | +712% |
| Q1 2026 | $11.8M | -51% |
| Q4 2025 | $73.4M | +55% |
| Q3 2025 | $47.2M | -22% |
| Q2 2025 | $6.9M | +$35M |
| Q1 2025 | $24M | -13% |
| Q4 2024 | $47.4M | -38% |
HOPE's free cash flow was $287M over the past year, up 129% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HOPE.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HOPE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HOPE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +316K shares |
| 1 year | 0% | +30.8K shares |
| 3 years | +6.9% | +8.3M shares |
| 5 years | +4.7% | +5.7M shares |
| Available history | +1.4% | +1.7M shares |
HOPE has 129M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $6.7M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | $2.8M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HOPE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | 0.1x | Very low |
HOPE has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HOPE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 12.2 | Oversold |
HOPE's weekly RSI is 47 (neutral) and its Stochastic is 12 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HOPE on valuation relative to its sector.
HOPE PE vs Financial Services Sector
| Metric | HOPE | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 3.5% below |
| PE % | 62 | 63 | 1 pt below |
HOPE is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HOPE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 3% below |
| 20 week MA | $13.7 | 4.8% below |
| 50 week MA | $12.6 | 3.3% above |
| 100 week MA | $11.7 | 12% above |
| 200 week MA | $11.3 | 16% above |
HOPE has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HOPE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $10.8 | -27% |
| 2021 | $10.8 | $14.5 | +35% |
| 2022 | $14.5 | $12.9 | -11% |
| 2023 | $12.9 | $12.1 | -6.4% |
| 2024 | $12.1 | $12.3 | +1.8% |
| 2025 | $12.3 | $11.3 | -8.5% |
| 2026 YTD | $11.3 | $13.1 | +16% |
HOPE has the edge over BAC on returns for 2026, with the stronger performance.